Association of SNPs in EGR3 and ARC with Schizophrenia Supports a Biological Pathway for Schizophrenia Risk

We have previously hypothesized a biological pathway of activity-dependent synaptic plasticity proteins that addresses the dual genetic and environmental contributions to schizophrenia. Accordingly, variations in the immediate early gene EGR3, and its target ARC, should influence schizophrenia susce...

Full description

Saved in:
Bibliographic Details
Published inPloS one Vol. 10; no. 10; p. e0135076
Main Authors Huentelman, Matthew J., Muppana, Leela, Corneveaux, Jason J., Dinu, Valentin, Pruzin, Jeremy J., Reiman, Rebecca, Borish, Cassie N., De Both, Matt, Ahmed, Amber, Todorov, Alexandre, Cloninger, C. Robert, Zhang, Rui, Ma, Jie, Gallitano, Amelia L.
Format Journal Article
LanguageEnglish
Published United States Public Library of Science 16.10.2015
Public Library of Science (PLoS)
Subjects
Online AccessGet full text
ISSN1932-6203
1932-6203
DOI10.1371/journal.pone.0135076

Cover

More Information
Summary:We have previously hypothesized a biological pathway of activity-dependent synaptic plasticity proteins that addresses the dual genetic and environmental contributions to schizophrenia. Accordingly, variations in the immediate early gene EGR3, and its target ARC, should influence schizophrenia susceptibility. We used a pooled Next-Generation Sequencing approach to identify variants across these genes in U.S. populations of European (EU) and African (AA) descent. Three EGR3 and one ARC SNP were selected and genotyped for validation, and three SNPs were tested for association in a replication cohort. In the EU group of 386 schizophrenia cases and 150 controls EGR3 SNP rs1877670 and ARC SNP rs35900184 showed significant associations (p = 0.0078 and p = 0.0275, respectively). In the AA group of 185 cases and 50 controls, only the ARC SNP revealed significant association (p = 0.0448). The ARC SNP did not show association in the Han Chinese (CH) population. However, combining the EU, AA, and CH groups revealed a highly significant association of ARC SNP rs35900184 (p = 2.353 x 10(-7); OR [95% CI] = 1.54 [1.310-1.820]). These findings support previously reported associations between EGR3 and schizophrenia. Moreover, this is the first report associating an ARC SNP with schizophrenia and supports recent large-scale GWAS findings implicating the ARC complex in schizophrenia risk. These results support the need for further investigation of the proposed pathway of environmentally responsive, synaptic plasticity-related, schizophrenia genes.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
Competing Interests: This research was supported in part by the 2004 Pfizer Fellowship in Biological Psychiatry, funded by Pfizer U.S. Pharmaceuticals, awarded to Amelia Gallitano. Dr. Gallitano was not an employee or consultant of Pfizer, and the science was performed independently without influence or direction from the company and did not involve product development for, or marketing of products of, the company. There are no restrictions on the sharing of data or materials. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.
Conceived and designed the experiments: ALG MJH. Performed the experiments: LM JJC JJP RR CNB AA VD RZ JM. Analyzed the data: ALG MJH LM JJC VD RZ JM AT MD. Contributed reagents/materials/analysis tools: ALG CRC RZ JM. Wrote the paper: ALG MJH LM JJC VD JM. Obtained permission for use of DNA Samples: CRC. Intellectual contribution to study design and provided editorial feedback: CRC.
ISSN:1932-6203
1932-6203
DOI:10.1371/journal.pone.0135076